PIK3CB and familial pancreatic carcinoma: Pathway analysis demonstrated that PI3K‐Akt was the most activated pathway in patients with pancreatic ITPN; the statistical associations considering all cancer types, based on the pathway analysis, were more significant in breast and hepatocellular cancers than in conventional pancreatic cancer (Figure S2).